{"id":"https://openalex.org/W2003192067","doi":"https://doi.org/10.1177/2325957413488189","title":"Hypersensitivity and Desensitization to Darunavir in a Case of HIV Infection with Triple-Class Drug Resistance","display_name":"Hypersensitivity and Desensitization to Darunavir in a Case of HIV Infection with Triple-Class Drug Resistance","publication_year":2013,"publication_date":"2013-06-18","ids":{"openalex":"https://openalex.org/W2003192067","doi":"https://doi.org/10.1177/2325957413488189","mag":"2003192067","pmid":"https://pubmed.ncbi.nlm.nih.gov/23778241"},"language":"en","primary_location":{"id":"doi:10.1177/2325957413488189","doi":"https://doi.org/10.1177/2325957413488189","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2325957413488189","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2325957413488189","source":{"id":"https://openalex.org/S4210205368","display_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","issn_l":"2325-9574","issn":["2325-9574","2325-9582"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/2325957413488189","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113513866","display_name":"Margalit Lorber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Margalit Lorber","raw_affiliation_strings":["Autoimmune Disease Unit, The Rappaport Faculty of Medicine, Rambam Medical Center, Technion \u2013 Israel Institute of Technology, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Autoimmune Disease Unit, The Rappaport Faculty of Medicine, Rambam Medical Center, Technion \u2013 Israel Institute of Technology, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110176484","display_name":"Salim Haddad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Salim Haddad","raw_affiliation_strings":["Pharmacy Department, The Rappaport Faculty of Medicine, Rambam Medical Center, Haifa, Israel","#N#2Pharmacy Department, The Rappaport Faculty of Medicine, Rambam Medical Center, Haifa, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, The Rappaport Faculty of Medicine, Rambam Medical Center, Haifa, Israel","institution_ids":["https://openalex.org/I2801301638"]},{"raw_affiliation_string":"#N#2Pharmacy Department, The Rappaport Faculty of Medicine, Rambam Medical Center, Haifa, Israel","institution_ids":["https://openalex.org/I2801301638"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113513866"],"corresponding_institution_ids":["https://openalex.org/I174306211"],"apc_list":{"value":2000,"currency":"USD","value_usd":2000},"apc_paid":{"value":2000,"currency":"USD","value_usd":2000},"fwci":0.7342,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.70279514,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"12","issue":"6","first_page":"378","last_page":"379"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darunavir","display_name":"darunavir","score":0.9309999942779541},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-desensitization","display_name":"drug desensitization","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.8029999732971191},{"id":"https://openalex.org/keywords/severe-cutaneous-adverse-reactions","display_name":"severe cutaneous adverse reactions","score":0.7639999985694885},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.7289999723434448},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9350000023841858},{"id":"https://openalex.org/keywords/hiv-viral-load","display_name":"HIV viral load","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.9845882654190063},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.8526089191436768},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.8064900636672974},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7349446415901184},{"id":"https://openalex.org/C2779779143","wikidata":"https://www.wikidata.org/wiki/Q3493547","display_name":"Desensitization (medicine)","level":3,"score":0.6696604490280151},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.5332267880439758},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4739532470703125},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.441877156496048},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4176098704338074},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36448657512664795},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.34626340866088867},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3115174472332001},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.235215425491333},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08742359280586243},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069454","descriptor_name":"Darunavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003888","descriptor_name":"Desensitization, Immunologic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024921","descriptor_name":"Drug Resistance, Multiple, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/2325957413488189","doi":"https://doi.org/10.1177/2325957413488189","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2325957413488189","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2325957413488189","source":{"id":"https://openalex.org/S4210205368","display_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","issn_l":"2325-9574","issn":["2325-9574","2325-9582"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","raw_type":"journal-article"},{"id":"pmid:23778241","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23778241","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the International Association of Providers of AIDS Care","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1177/2325957413488189","doi":"https://doi.org/10.1177/2325957413488189","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2325957413488189","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/2325957413488189","source":{"id":"https://openalex.org/S4210205368","display_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","issn_l":"2325-9574","issn":["2325-9574","2325-9582"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the International Association of Providers of AIDS Care (JIAPAC)","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8500000238418579}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2003192067.pdf"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W80745537","https://openalex.org/W1904151121","https://openalex.org/W1965922975","https://openalex.org/W1968079165","https://openalex.org/W2088433385","https://openalex.org/W2090157578","https://openalex.org/W2096914206","https://openalex.org/W2103513664","https://openalex.org/W2139772076","https://openalex.org/W2154556376","https://openalex.org/W2169979678","https://openalex.org/W2468968192"],"related_works":["https://openalex.org/W2468968192","https://openalex.org/W2169979678","https://openalex.org/W2120490805","https://openalex.org/W2033352290","https://openalex.org/W2306573698","https://openalex.org/W2028560318","https://openalex.org/W2124488515","https://openalex.org/W2041815399","https://openalex.org/W2756346985","https://openalex.org/W2032451005"],"abstract_inverted_index":{"We":[0],"report":[1],"on":[2],"a":[3,12,19,42,74,129],"case":[4],"of":[5,69,85,92],"severe":[6,75],"cutaneous":[7,79],"reaction":[8,81,95],"to":[9,24,52,89,108,112],"darunavir/r":[10,70,118],"and":[11,31,59,115,152],"successful":[13],"desensitization":[14,130,138],"protocol.":[15],"The":[16],"patient":[17,72,148],"was":[18,50,56,98,106,119,132,140],"41-yr":[20],"old":[21],"female.":[22],"known":[23],"be":[25,109],"HIV":[26,60,154],"infective":[27],"for":[28],"18":[29],"years":[30],"who":[32],"had":[33,46],"received":[34],"several":[35],"drug":[36],"regiments":[37],"in":[38,123],"the":[39,71,90,93,101,104,147],"past.":[40],"As":[41],"consequence,":[43],"her":[44,153],"virus":[45,105],"triple-class":[47,126],"mutations":[48],"but":[49],"susceptible":[51,110],"darunavir/r.":[53,116],"Her":[54],"CD4":[55],"200":[57],"cells/mm(3)":[58],"viral":[61,155],"load":[62,156],"56,000":[63],"copies/mL.":[64,160],"Eight":[65],"days":[66],"after":[67,137,145],"initiation":[68],"developed":[73],"pruritic":[76],"vesicular":[77],"extended":[78],"allergic":[80,94],"which":[82],"required":[83],"cessation":[84],"all":[86],"drugs.":[87],"Due":[88],"severity":[91],"no":[96],"rechallenge":[97],"done.":[99],"After":[100],"patient's":[102],"recovery,":[103],"found":[107],"only":[111],"maraviroc,":[113],"raltegravir,":[114],"Since":[117],"an":[120],"essential":[121],"component":[122],"treating":[124],"this":[125],"mutated":[127],"virus,":[128],"protocol":[131,139],"applied":[133,141],"successfully.":[134,142],"Six":[135,143],"months":[136,144],"desensitization,":[146],"is":[149],"asymptomatic,":[150],"compliant,":[151],"remains":[157],"at":[158],"<20":[159]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}